News Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
4.38 ^USD	-1.13%		-60.18%	-65.65%

May. 08	Top Midday Decliners	MT
May. 08	UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Decliners	May. 08	MT
UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	May. 08	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	May. 08	MT
Top Premarket Decliners	May. 08	MT
Truist Securities Downgrades Treace Medical Concepts to Hold From Buy, Lowers Price Target to $7 From $17	May. 08	MT
BTIG Downgrades Treace Medical Concepts to Neutral From Buy	May. 08	MT
JPMorgan Downgrades Treace Medical Concepts to Neutral From Overweight, Cuts Price Target to $8 From $15	May. 08	MT
Stifel Downgrades Treace Medical Concepts to Hold From Buy, Cuts Price Target to $6 From $15	May. 08	MT
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million	May. 08	MT
Treace Medical Concepts: Q1 Earnings Snapshot	May. 07	AQ
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q1 Revenue $51.1M, vs. Street Est of $49.1M	May. 07	MT
Transcript : Treace Medical Concepts, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Treace Medical Concepts Reports First Quarter 2024 Financial Results	May. 07	AQ
Treace Medical Concepts, Inc. Revises Earnings Guidance for the Full-Year 2024	May. 07	CI
Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour	Apr. 24	AQ
Treace to Present at Bank of America Health Care Conference	Apr. 17	GL
Treace Announces First Annual National Bunion Day	Apr. 16	GL
Treace to Report First Quarter 2024 Financial Results	Apr. 09	GL
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	Mar. 25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Summary

Filters